Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 January 2024 | Story Gerda-Marié van Rooyen | Photo Chris Nelson
Dr Maryam Amra Jordaan
Dr Maryam Amra Jordaan, co-founded SA Rebuilders.

Only 16% of plastic gets recycled in South Africa, despite technological advancements. While the Extended Producer Responsibility (EPR) Regulation of 2021 assigns post-consumer recycling responsibility to producers, substantial efforts are needed to develop effective waste management strategies, heighten public awareness, discover practical solutions, and hold plastic-producing companies accountable.

Prioritising environmental sustainability

Dr Maryam Amra Jordaan co-founded SA Rebuilders with her husband, Yasar Amra, in 2016. By combining 3D printing, chemistry, and plastic recycling, they tackle socio-economic issues while prioritising environmental sustainability. As the daughter of a miner from Kimberley, Dr Jordaan is committed to mitigating the negative effects that industries have on the health, environment, and social aspects of local communities. She was honoured with an Alumni Cum Laude Award from the University of the Free State (UFS) for her work in this regard.

Dr Jordaan’s academic journey at the UFS from 2001 to 2013 includes a BSc in Chemistry and Physiology, BSc Honours, MSc, and a PhD in Organic Chemistry. She dedicated five years to lecturing and research on the Qwaqwa Campus and four years at the Mangosuthu University of Technology (MUT). During this time, she authored 19 pharmaceutical and environmental chemistry research papers and won numerous national and international awards. She entered the UFS with dreams of assisting in some way and ended up helping to solve the Sustainable Development Goals (SDGs).

“Remarkable potential for rapid prototyping and supply chain resilience through digitisation exists, but the current energy crisis hampers the full realisation of 3D printing’s potential,” Dr Jordaan explains. Added to this, is the complex endeavour of becoming a 3D engineer. “Expertise in materials science and project management is equally essential. Creativity, quick learning, and meticulous attention to detail are all characteristics necessary to excel as a 3D engineer.”

Seeking out biodegradable product alternatives

Dr Jordaan stresses the need for effective waste management, awareness, practical solutions, and accountability for individuals and plastic-producing companies. Therefore, she promotes reusable and recyclable shopping bags, among others, and instils this behaviour in her children. The Amras actively seek out biodegradable product alternatives, as they are fully aware of the environmental impact of the manufacturing industry.

They incorporated this ideology in the manufacturing process of organic butter by transforming the plastic waste from this process into a 3D filament. This product is currently undergoing SABS testing, after which it will be available to the local market.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept